COVID-19 booster doses in pregnancy and global vaccine equity.
作者信息
Kalafat Erkan, Magee Laura A, von Dadelszen Peter, Heath Paul, Khalil Asma
机构信息
Department of Obstetrics and Gynecology, Koc University School of Medicine, Istanbul, Turkey.
Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, UK.
出版信息
Lancet. 2022 Mar 5;399(10328):907-908. doi: 10.1016/S0140-6736(22)00166-0. Epub 2022 Feb 18.
Abstract
摘要
相似文献
1
COVID-19 booster doses in pregnancy and global vaccine equity.孕期的新冠病毒病加强针与全球疫苗公平性
Lancet. 2022 Mar 5;399(10328):907-908. doi: 10.1016/S0140-6736(22)00166-0. Epub 2022 Feb 18.
2
COVID-19 vaccine equity and booster doses.新冠疫苗公平性与加强针
Lancet Infect Dis. 2021 Sep;21(9):1193. doi: 10.1016/S1473-3099(21)00486-2. Epub 2021 Aug 13.
3
Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G Levels After the Pfizer-BioNTech Booster Dose for Coronavirus Disease 2019 (COVID-19) Vaccination During the Second Trimester of Pregnancy.母体和新生儿 2019 年冠状病毒病（COVID-19）疫苗接种第二孕期接种辉瑞-生物技术公司 COVID-19 疫苗加强针后严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）免疫球蛋白 G 水平。
Obstet Gynecol. 2022 Aug 1;140(2):187-193. doi: 10.1097/AOG.0000000000004867. Epub 2022 May 27.
4
Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.分析新加坡成年人接种 2 剂 mRNA COVID-19 或灭活 SARS-CoV-2 疫苗以及接种加强针后的 COVID-19 发病率和严重程度。
JAMA Netw Open. 2022 Aug 1;5(8):e2228900. doi: 10.1001/jamanetworkopen.2022.28900.
5
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial.同源加强接种 SARS-CoV-2 重组刺突蛋白疫苗（NVX-CoV2373）的安全性和免疫原性：一项随机、安慰剂对照、2 期临床试验的二次分析。
Lancet Infect Dis. 2022 Nov;22(11):1565-1576. doi: 10.1016/S1473-3099(22)00420-0. Epub 2022 Aug 10.
6
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.免疫实践咨询委员会关于使用二价加强针 COVID-19 疫苗的临时建议-美国，2022 年 10 月。
MMWR Morb Mortal Wkly Rep. 2022 Nov 11;71(45):1436-1441. doi: 10.15585/mmwr.mm7145a2.
7
Primary COVID-19 vaccine cycle and booster doses efficacy: analysis of Italian nationwide vaccination campaign.主要 COVID-19 疫苗接种周期和加强剂量的效果：意大利全国疫苗接种运动分析。
Eur J Public Health. 2022 Apr 1;32(2):328-330. doi: 10.1093/eurpub/ckab220.
8
Adjudicating the logistics of COVID-19 vaccine boosters from a global perspective.从全球视角裁定 COVID-19 疫苗加强针的物流问题。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2020572. doi: 10.1080/21645515.2021.2020572. Epub 2022 Jan 13.
9
Immunoassay and mass cytometry revealed immunological profiles induced by inactivated BBIBP COVID-19 vaccine.免疫测定法和液质联用技术揭示了 BBIBP COVID-19 疫苗诱导的免疫谱。
J Med Virol. 2022 Nov;94(11):5206-5216. doi: 10.1002/jmv.27983. Epub 2022 Jul 19.
10
Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy.孕期接种第三针 SARS-CoV-2 疫苗（加强针）的安全性。
Am J Obstet Gynecol MFM. 2022 Jul;4(4):100637. doi: 10.1016/j.ajogmf.2022.100637. Epub 2022 Apr 7.
引用本文的文献
1
Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites. Nested case-control analysis of the immunization-associated risk: A study protocol.妊娠期接种 COVID-19 疫苗的孕妇母婴不良事件描述：CLAP 网络哨点的嵌套病例对照分析：一项免疫相关风险研究方案。
BMJ Open. 2024 Jan 29;14(1):e073095. doi: 10.1136/bmjopen-2023-073095.
2
IgG antibody levels against the SARS-CoV-2 spike protein in mother-child dyads after COVID-19 vaccination.母亲-儿童对 COVID-19 疫苗接种后 SARS-CoV-2 刺突蛋白的 IgG 抗体水平。
Infection. 2024 Jun;52(3):813-824. doi: 10.1007/s15010-023-02111-x. Epub 2023 Oct 28.
3
An Update on COVID-19 Vaccination and Pregnancy.新型冠状病毒肺炎疫苗接种与妊娠的最新情况
J Pers Med. 2023 May 6;13(5):797. doi: 10.3390/jpm13050797.
4
Protecting the Offspring, the Gift of Maternal Immunization: Current Status and Future Perspectives.保护后代，母体免疫的馈赠：现状与未来展望
Vaccines (Basel). 2022 Nov 18;10(11):1953. doi: 10.3390/vaccines10111953.
5
Covid-19 third vaccination during pregnancy: maternal and neonatal outcomes-a retrospective study.Covid-19 孕期第三针疫苗接种：母婴结局——一项回顾性研究。
Arch Gynecol Obstet. 2023 Oct;308(4):1197-1205. doi: 10.1007/s00404-022-06786-9. Epub 2022 Sep 26.
6
COVID-19 Vaccination Status among Pregnant and Postpartum Women-A Cross-Sectional Study on More Than 1000 Individuals.孕妇和产后妇女的新冠疫苗接种状况——一项针对1000多人的横断面研究
Vaccines (Basel). 2022 Jul 25;10(8):1179. doi: 10.3390/vaccines10081179.
7
COVID-19 vaccine and pregnancy outcomes: A systematic review and meta-analysis.COVID-19 疫苗与妊娠结局：系统评价和荟萃分析。
Int J Gynaecol Obstet. 2022 Dec;159(3):651-661. doi: 10.1002/ijgo.14336. Epub 2022 Jul 29.
8
Vaccine Protection Through Placenta and Breastfeeding: The Unmet Topic in COVID-19 Pandemic.通过胎盘和母乳喂养实现疫苗保护：COVID-19 大流行中未满足的议题。
Front Immunol. 2022 Jun 3;13:910138. doi: 10.3389/fimmu.2022.910138. eCollection 2022.
9
The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants.科兴新冠疫苗第三针诱导广泛而有效的适应性免疫应答，能识别 SARS-CoV-2 德尔塔和奥密克戎变异株。
Emerg Microbes Infect. 2022 Dec;11(1):1524-1536. doi: 10.1080/22221751.2022.2081614.
10
Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy.系统评价和荟萃分析 COVID-19 疫苗接种在妊娠中的有效性和围产期结局。
Nat Commun. 2022 May 10;13(1):2414. doi: 10.1038/s41467-022-30052-w.
本文引用的文献
1
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.BNT162b2 mRNA COVID-19 疫苗加强针在预防以色列重症结局的有效性：一项观察性研究。
Lancet. 2021 Dec 4;398(10316):2093-2100. doi: 10.1016/S0140-6736(21)02249-2. Epub 2021 Oct 29.
2
COVID-19 vaccination in pregnancy-number needed to vaccinate to avoid harm.孕期接种新冠病毒疫苗——避免伤害所需的接种人数。
Lancet Infect Dis. 2021 Dec;21(12):1627. doi: 10.1016/S1473-3099(21)00691-5. Epub 2021 Nov 2.
3
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.辉瑞-BioNTech 新冠疫苗接种 6 个月后免疫体液反应逐渐减弱。
N Engl J Med. 2021 Dec 9;385(24):e84. doi: 10.1056/NEJMoa2114583. Epub 2021 Oct 6.
4
An internally validated prediction model for critical COVID-19 infection and intensive care unit admission in symptomatic pregnant women.针对有症状孕妇的重症 COVID-19 感染和入住重症监护病房的内部验证预测模型。
Am J Obstet Gynecol. 2022 Mar;226(3):403.e1-403.e13. doi: 10.1016/j.ajog.2021.09.024. Epub 2021 Sep 25.
5
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.辉瑞-BioNTech 信使核糖核酸新冠病毒疫苗 6 个月的安全性和有效性
N Engl J Med. 2021 Nov 4;385(19):1761-1773. doi: 10.1056/NEJMoa2110345. Epub 2021 Sep 15.
6
SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity.孕期接种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗：实现公平的独特契机。
Lancet. 2021 Sep 11;398(10304):951. doi: 10.1016/S0140-6736(21)01756-6. Epub 2021 Aug 12.
7
COVID-19 vaccination during pregnancy: coverage and safety.妊娠期 COVID-19 疫苗接种：覆盖范围和安全性。
Am J Obstet Gynecol. 2022 Feb;226(2):236.e1-236.e14. doi: 10.1016/j.ajog.2021.08.007. Epub 2021 Aug 10.
Zotero 插件